| Literature DB >> 16485478 |
Juan-Carlos Navarro1, Gladys Medina, Clovis Vasquez, Lark L Coffey, Eryu Wang, Alexander Suárez, Hernán Biord, Marlene Salas, Scott C Weaver.
Abstract
Five years after the apparent end of the major 1995 Venezuelan equine encephalitis (VEE) epizootic/epidemic, focal outbreaks of equine encephalitis occurred in Carabobo and Barinas States of western Venezuela. Virus isolates from horses in each location were nearly identical in sequence to 1995 isolates, which suggests natural persistence of subtype IC VEE virus (VEEV) strains in a genetically stable mode. Serologic evidence indicated that additional outbreaks occurred in Barinas State in 2003. Field studies identified known Culex (Melanoconion) spp. vectors and reservoir hosts of enzootic VEEV but a dearth of typical epidemic vectors. Cattle serosurveys indicated the recent circulation of enzootic VEEV strains, and possibly of epizootic strains. Persistence of VEEV subtype IC strains and infection of horses at the end of the rainy season suggest the possibility of an alternative, cryptic transmission cycle involving survival through the dry season of infected vectors or persistently infected vertebrates.Entities:
Mesh:
Year: 2005 PMID: 16485478 PMCID: PMC3367636 DOI: 10.3201/eid1112.050533
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Figure 1Map of Venezuela showing locations of the 1995 Venezuelan equine encephalitis outbreak and the small outbreaks of 2000 and 2003, along with surveillance study sites.
Results of hemagglutination inhibition assays to detect Venezuelan equine encephalitis virus antibodies in horses
| Municipality | No. serum samples tested | No. positive (%) |
|---|---|---|
| Obispos | 199 | 46 (23) |
| Zamora | 128 | 61 (48) |
| Bolivar | 18 | 0 |
| Pedraza | 23 | 10 (44) |
| Barinas | 172 | 37 (22) |
| Arismendi | 9 | 0 |
| Sucre | 65 | 1 (2) |
| A. Arvelo Torrealba | 5 | 1 (20) |
| Total | 619 | 174 (28) |
Serologic results from equines, bovines, and wild mammals in regions of the 2000 and 2003 VEEV outbreaks*
| Location | Dates of collection | Species or common name | No. collected | Fraction HI seropositive | Fraction of HI-positive samples positive by PRNT | PRNT titers |
|---|---|---|---|---|---|---|
| Obispos | May 2002 |
| 10 | 0/10 | NT | NT |
|
| 47 | 0/47 | NT | NT | ||
| Zamora | May 2003 |
| 2 | 0/2 | NT | NT |
|
| 1 | 0/1 | NT | NT | ||
|
| 13 | 0/13 | NT | NT | ||
|
| 1 | 0/1 | NT | NT | ||
|
| 2 | 0/2 | NT | NT | ||
|
| 18 | 0/18 | NT | NT | ||
|
| 2 | 0/2 | NT | NT | ||
| Bovines | 4 | 0/4 | NT | NT | ||
| June 2003 |
| 6 | 1/6 | 0/1 | <20 | |
| Sep 2003 |
| 1 | 1/1 | 0/1 | <20 | |
|
| 11 | 4/11 | 0/4 | <20 | ||
|
| 1 | 1/1 | 0/1 | <20 | ||
| Bovines | 20 | 0/20 | NT | NT | ||
| Nov 2003 |
| 10 | 0/10 | NT | NT | |
|
| 1 | 1/1 | NT | NT | ||
| Arismendi | Oct–Nov 2003 | Bovines | 48 | 12/48 | 8/12 | 40–640 |
| Antonio Jose de Sucre/Zamora | June 2003 |
| 3 | 0/3 | NT | NT |
|
| 1 | 0/1 | NT | NT | ||
| Totals | Wild mammals | 130 | 7/130 (5%) | 0/7 | <20 | |
| Bovines | 72 | 12/72 (17%) | 8/12 | 40–640 |
*VEEV, Venezuelan equine encephalitis virus; HI, hemagglutination inhibition; PRNT, plaque reduction neutralization test; NT, not tested.
Results of the blocking ELISA to determine VEEV subtypes producing seroconversion in HI- and PRNT-positive bovines from Arismendi municipality, Barinas State, Venezuela*
| Sample no.† | % inhibition of epizootic–specific MAb 1A3A–5 binding at indicated serum dilution | % inhibition of enzootic–specific MAb 1A1B–9 binding at indicated serum dilution | ||||
|---|---|---|---|---|---|---|
| 1:4 | 1:12 | 1:36 | 1:4 | 1:12 | 1:36 | |
| 156 | 3.0 | 8.5 | –5.0 | 52.4 | 17.8 | –34.3 |
| 158 | 12.4 | 13.9 | –3.6 | 27.0 | –20.4 | –37.0 |
| 166 | 35.6 | 12.5 | 6.2 | 30.7 | 42.7 | –21.0 |
| 167 | 59.6 | 42.0 | 3.7 | 65.7 | 17.1 | –9.9 |
| 172 | –11.7 | –15.4 | –13.8 | 37.5 | 32.1 | –19.0 |
| 175 | 8.2 | 5.0 | 2.1 | 48.5 | 21.5 | –20.0 |
| 178 | 23.1 | 15.1 | 2.2 | 69.7 | 44.9 | –5.9 |
| 204 | –1.1 | –10.8 | –22.4 | 75.8 | 56.4 | 29.7 |
| Negative control† | 4.1 | 6.6 | 5.4 | 15.2 | 23.1 | –5.7 |
| Negative control† | 9.4 | 14.1 | 12.0 | 8.0 | 14.5 | 15.6 |
| Negative control† | 5.8 | 11.4 | 11.3 | 17.5 | 23.2 | 11.0 |
| Positive control† | 18.8 | 9.5 | –8.0 | 65.3 | 51.0 | 29.0 |
| Positive control† | 16.4 | 1.4 | 1.7 | 50.1 | 16.7 | 18.9 |
*ELISA, enzyme-linked immunosorbent assay; VEEV, Venezuelan equine encephalitis virus; HI, hemagglutination-inhibition; PRNT, plaque reduction neutralization test; MAb, monoclonal antibody.
†Negative controls are bovine sera from locations with no history of VEE; positive controls are human sera from virus isolation–confirmed, subtype ID VEEV infections (note that the assay is species–independent).
Mosquitoes collected in the regions affected by the 2000 and 2003 Venezuelan equine encephalitis outbreaks
| Species | Study site | Total | ||
|---|---|---|---|---|
| Zamora | Obispos | Arismendi | ||
| 133 | 924 | 25 | 1,082 | |
| 26 | 15 | 41 | ||
| 1 | 1 | |||
| 1 | 1 | |||
| 13 | 6 | 19 | ||
| 5 | 5 | |||
| 24 | 120 | 144 | ||
| 800 | 132 | 45 | 977 | |
|
| 39 | 18 | 57 | |
|
| 2 | 5 | 7 | |
|
| 1 | 1 | ||
|
| 7 | 3 | 10 | |
|
| 2 | 2 | ||
|
| 6 | 44 | 9 | 59 |
|
| 17 | 5 | 22 | |
|
| 12 | 1 | 13 | |
| 1 | 1 | |||
| 2 | 2 | |||
|
| 2 | 2 | ||
|
| 6 | 70 | 76 | |
|
| 5 | 5 | ||
|
| 7 | 7 | ||
|
| 10 | 169 | 179 | |
|
| 4 | 4 | ||
|
| 3 | 3 | ||
| 2 | 2 | |||
*Proven enzootic vectors of Venezuelan equine encephalitis virus.
†Suspected bridge vectors.
Sequence comparisons between the year 2000 VEEV virus equine isolates and those from the 1995 epidemic*
| Virus strain† | State of isolation | Horse sample | Date of collection | Passage history | Comparisons to 1995 strain 6119 | Comparisons to 1995 strain 3908 | ||
|---|---|---|---|---|---|---|---|---|
| nt differences‡ | aa differences§ | nt differences¶ | aa differences# | |||||
| 254934 | Barinas | Brain | Apr 10, 2000 | sm-1 | C1248T | – | A1443G | – |
| G6325A | nsP4/V208I | T4975C | ||||||
| G9165A | E2/E199K | C5292T | – | |||||
| T10913C | – | T5475C | – | |||||
| C11237T | – | G6325A | nsP4/V208I | |||||
| A6498T | – | |||||||
| G9159A | E2/E199K | |||||||
| C11237T | – | |||||||
| 255010 | Barinas | Serum | Feb 20, 2000 | sm-2 | C1248T | – | A1443G | – |
| T10913C | – | T4975C | – | |||||
| C11237T | – | C5292T | – | |||||
| T5475C | – | |||||||
| A6498T | – | |||||||
| G9159A | E2/E199K | |||||||
| C11237T | – | |||||||
| 255005* | Barinas | Serum | Feb 20, 2000 | sm-3 | 0 | – | 0 | – |
| 255057* | Carabobo | Brain | April, 2000 | sm-1, V-1 | 0 | – | 0 | – |
*VEEV, Venezuelan equine encephalitis virus; nt, nucleotide; aa, amino acid.
†Only partial PE2 envelope glycoprotein precursor gene sequences determined (817 nucleotides).
‡Strain 6119 residue is indicated first, followed by genome position and year 2000 strain residue.
§Strain 6119 residue is indicated first, followed by protein and amino acid position and year 2000 strain residue.
¶Strain 3908 residue is indicated first, followed by genome position and year 2000 strain residue.
#Strain 3908 residue is indicated first, followed by protein and amino acid position and year 2000 strain residue.
Figure 2Phylogenetic tree generated from maximum parsimony analysis of genomic sequences of Venezuelan equine encephalitis virus (VEEV) strains 255010 and 254934 and homologous GenBank sequences from the 1962–64 and 1995 VEEV outbreaks, as well as other representative VEE complex alphavirus strains. Numbers indicate bootstrap values for groupings to the right. Enlargement on the lower left shows the 1962–64 and 1995–2000 clades, with numbers indicating nucleotide substitutions accompanying VEEV evolution.